Experts developing immune-enhancing therapies to treat TB: Study

​Host-directed therapies (HDT) aim to strengthen the body's immune responses and represent an underexplored opportunity to improve treatment of TB, particularly MDR-TB. HDT are designed to target several immune pathways in infected cells to restore or induce antimicrobial functions instead of inhibiting bacterial growth directly.

from Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/5y17Cdv
via